|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/biotechnology-business-law-and-science/
课程评论：没有评论
课程名称：生物技术/生物技术商业、政策、法律与科学 课程概述：本课程旨在深入了解生物技术的商业运作，学习如何启动和管理生物技术公司，以及如何更好地满足生物技术公司的需求。课程内容超越了单纯的“科学面向非科学家”或“小型MBA”课程，详细描述了推动生物技术行业发展的科学、政治、监管和商业因素之间的融合，及其定义的行业范围。 主要内容包括： - 生物技术的发展 - 生物技术科学的通俗介绍 - 药物开发 - 法律、法规与政策 - 知识产权 - 专利 - 生物技术的商业运作 - 财务 - 营销 - 管理 本课程基于《构建生物技术》（Building Biotechnology）一书，这是生物技术商业领域的领先教材，已被50多所学校采用。课程讲师为Yali Friedman博士，他是《商业生物技术期刊》的出版人，并曾在国家卫生研究院教授生物技术管理课程。希望你能享受这门课程，就像我在设计过程中一样。 课程信息还包括关于药物开发的内容，感兴趣的学生可以查看我在Udemy上的另一门课程：仿制药进入与品牌药物生命周期管理。 关于讲师：Yali Friedman博士拥有超过20年的生命科学商业情报经验，最近被《科学美国人》评选为生物技术领域100位最具影响力的人物之一。他也是MBA级教材《构建生物技术》的作者及《商业生物技术期刊》的出版人。
Learn the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies. Going beyond simple 'science for non-scientists' or 'mini MBA' offerings, this course describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope. Topics covered include:The development of biotechnologyAn accessible introduction to the science of biotechnologyDrug developmentLaws, Regulations, and PolicyIntellectual PropertyPatentsThe Business of BiotechnologyFinanceMarketingManagement This course is based on the leading business-of-biotechnology text, "Building Biotechnology," which has been adopted by more than 50 schools, and is taught by Yali Friedman, Ph.D., publisher of the Journal of Commercial Biotechnology and a former instructor of biotechnology management at the National Institutes of Health. I hope you enjoy this course as much as I did putting it together.For those interested in drug development specifically, you can also check out my other Udemy Course: Generic Drug Entry & Branded Drug Lifecycle ManagementAbout the Author:Yali Friedman, Ph.D. has more than 20 years experience providing business intelligence to life science companies. He was recently named one of the 100 most influential people in biotechnology by Scientific American. He is also author of the MBA-level textbook Building Biotechnology and publisher of the Journal of Commercial Biotechnology.
